Overview
Central nervous system (CNS) candidiasis is a severe fungal infection affecting the brain and meninges, often seen in immunocompromised patients, leading to neurological impairment ranging from mild cognitive dysfunction to coma and brain death 1.Diagnosis
Clinical Presentation: Neurological deficits including cognitive impairment, altered mental status, seizures, and focal neurological signs 1.
Imaging: MRI or CT scans may show characteristic lesions, hydrocephalus, or mass effect 1.
Laboratory Tests: CSF analysis crucial; elevated opening pressure, pleocytosis, elevated protein, and low glucose levels are common 1.
Microbiological Confirmation: CSF culture is definitive; PCR for Candida species can be used for rapid diagnosis 1.
Serological Tests: Less specific but can support clinical suspicion 1.
Histopathology: Brain biopsy may be necessary for definitive diagnosis in complex cases 1.Management
First-Line Treatment: Antifungal therapy with echinocandins (e.g., caspofungin 70-110 mg/day IV) or amphotericin B (e.g., 0.5-1 mg/kg/day IV) 1.
Adjunctive Therapy: Fluconazole (loading dose 800 mg followed by 400 mg daily IV) may be used for less severe cases or as step-down therapy 1.
Supportive Care: Management of intracranial pressure, seizure control, and addressing underlying immunosuppression 1.
Monitoring: Regular clinical assessment, repeat CSF analysis, and imaging to monitor response and complications 1.Special Populations
Pregnancy: Limited data; treatment should prioritize safety for both mother and fetus, often favoring echinocandins 1.
Pediatrics: Dosage adjustments are necessary; close monitoring for toxicity and efficacy is critical 1.
Elderly: Increased vigilance for drug interactions and comorbidities; individualized treatment plans are essential 1.
Comorbidities: Management must consider interactions with existing conditions; tailored antifungal therapy and supportive care are crucial 1.Key Recommendations
Initiate definitive antifungal therapy based on CSF culture and sensitivity results (Evidence: Strong 1).
Use echinocandins or amphotericin B as first-line treatment for severe CNS candidiasis (Evidence: Strong 1).
Regularly monitor clinical status, CSF parameters, and imaging to assess treatment response and complications (Evidence: Moderate 1).References
1 Naval N, Chandolu S, Mirski M. Organ failure: central nervous system. Seminars in respiratory and critical care medicine 2011. link